| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10232276 | Current Opinion in Biotechnology | 2011 | 7 Pages |
Abstract
⺠Polymer therapeutics are considered amongst the most successful nanomedicines. ⺠Future directions: new targets, combination therapy, controlled polymer architecture, advanced characterization techniques. ⺠An exponentially growing industrial pipeline on nanoconjugates is currently available. ⺠Understanding nanoconjugate features that govern clinical risk-benefit is leading to clinical biomarkers. ⺠Opaxio⢠first example of individualized medicine with polymer-drug conjugates.
Related Topics
Physical Sciences and Engineering
Chemical Engineering
Bioengineering
Authors
Fabiana Canal, Joaquin Sanchis, MarÃa J Vicent,